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Abstract
Dystroglycan (DG) is a highly glycosylated protein complex that links the cytoskeleton with
the extracellular matrix, mediating fundamental physiological functions such as mechanical
stability of tissues, matrix organization and cell polarity. A crucial role in the glycosylation of
the DG α subunit is played by its own N-terminal region that is required by the glycosyltrans-
ferase LARGE. Alteration in this O-glycosylation deeply impairs the high affinity binding to
other extracellular matrix proteins such as laminins. Recently, three missense mutations in the
gene encoding DG, mapped in the α-DG N-terminal region, were found to be responsible for
hypoglycosylated states, causing congenital diseases of different severity referred as primary
dystroglycanopaties.To gain insight on the molecular basis of these disorders, we investigated
the crystallographic and solution structures of these pathological point mutants, namely V72I,
D109N and T190M. Small Angle X-ray Scattering analysis reveals that these mutations affect
the structures in solution, altering the distribution between compact and more elongated con-
formations. These results, supported by biochemical and biophysical assays, point to an
altered structural flexibility of the mutant α-DG N-terminal region that may have repercussions
on its interaction with LARGE and/or other DG-modifying enzymes, eventually reducing their
catalytic efficiency.
Introduction
Dystroglycan (DG), a ubiquitous membrane receptor belonging to the glycoprotein complex
associated to dystrophin, plays a crucial role in the stability of the plasma membrane, especially
in skeletal muscle tissues where it is highly expressed [1]. A single gene, DAG1, encodes for a
protein precursor, which is proteolytically cleaved in two subunits, alpha-dystroglycan (α-DG),
located at the extracellular side of the plasma membrane where it binds several extracellular
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matrix proteins, and beta-dystroglycan (β-DG), which is a transmembrane protein that interacts
with dystrophin in the cytoplasm [2]. Many studies have been devoted to the structural charac-
terization of the α-DG subunit. A pioneering electron microscopy study of α-DG revealed its
dumbbell-like shape [3]. The molecular structure of the N-terminal region of α-DG (α-DG-Nt)
was later determined at high resolution by X-ray crystallography, revealing the presence of two
domains, an immunoglobulin-like (Ig-like) domain and a domain similar to the small subunit
ribosomal protein S6 of T. termophilus (S6 domain), connected by a flexible loop [4]. The high
resolution structure of the α-DG C-terminal domain is still elusive, although a computational
study envisaged that this domain is also likely to possess an Ig-like fold, followed by a disordered
part at the C-terminus [5]. A biochemical characterization confirmed a highly disordered con-
formation for the mucin-like central domain of α-DG [6], that is decorated and stabilized in
vivo by specific O-mannosyl glycans built by a complex array of enzymes [7]. Among these, par-
ticularly worth of mention is the bifunctional Like-acetylglucosaminyltransferase (LARGE),
which adds the repeating heterodisaccharide [-glucuronic acid-β1,3-xylose-α1,3-]n to a glycan
anchored at Thr317 and Thr319 in the mucin-like domain [8]. This region of the protein plays
a crucial functional role, as its protruding carbohydrate moieties are known to mediate the
interactions with laminin and other extracellular proteins containing laminin globular (LG)
domains [9]. Indeed, many congenital muscular dystrophies, due to mutations affecting the
genes encoding for glycosyltransferases belonging to the glycosylation pathway of α-DG, are
characterized by hypoglycosylated forms of α-DG that are unable to interact with laminin,
compromising the stability of sarcolemma [10]. Noteworthy, it has been shown that α-DG-Nt is
necessary for recruiting LARGE [11] and some pathological conditions that are caused by mis-
sense mutations in the DAG1 map within the α-DG-Nt.
The first identified mutation (T192M), associated to a form of limb-girdle muscular dystro-
phy and cognitive impairment, prevents the correct glycosylation of α-DG resulting in
impaired laminin binding. It was shown that the T192M mutation weakens the interaction
between α-DG-Nt and LARGE, strongly reducing the ability of the latter to decorate α-DG
with the proper carbohydrate moiety [12]. More recently, two additional mutations, namely
V74I and D111N, located on the Ig-like domain surface facing the S6 domain within α-
DG-Nt, have been found in a seven years old compound heterozygous patient, who displays
mild muscular dystrophy and asymptomatic hyperCKemia. Also in this case, a biochemical
analysis carried out on the muscular tissues of the patient revealed the presence of a hypoglyco-
sylated form of α-DG that cannot bind to laminin [13].
In order to investigate the molecular mechanisms underlining these diseases, we analyzed
the impact of the three afore mentioned pathological missense mutations on the conforma-
tional stability and on the overall structure of α-DG-Nt. In particular, we focused on the
murine α-DG-Nt region, fully validated as a model for the human counterpart [14], carrying
the three pathological missense mutations V72I, D109N and T190M that correspond to their
topological counterparts V74I, D111N and T192M in human DG.
Even though the missense mutations V72I and D109N do not alter the overall fold of
α-DG-Nt, as previously assessed by X-ray crystallography for the mutant T190M [15],
Small Angle X-ray Scattering (SAXS) analysis (supported by limited proteolysis and Dif-
ferential Scanning Fluorimetry (DSF) experiments) highlights a more complex dynamic
behavior of α-DG-Nt in solution that is remarkably affected by the three pathological
mutations. The resulting altered conformations may impact on the interactions of α-DG
with LARGE, negatively influencing LARGE recruiting and ultimately the proper matura-
tion of α-DG.
Structural characterization of the V72I, D109N and T190M mutants of the α-DG N-terminal domain
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Materials and methods
DNA constructs, site-directed mutagenesis and protein expression and
purification
The point mutations V72I and D109N were introduced within the murine α-DG(50–313)
construct, carrying the additional mutation R166H, to improve its proteolytical stability, (here-
inafter WT), cloned in pHis-Trx [4], by the QuikChange site-directed mutagenesis kit (Strata-
gene) as previously reported for T190M [15]. The following primers were employed to insert
the two mutations:
V72I Forward: 5’-CCTGATGGCACGGCTGTCATCGGGCGCTCATTTCGAGTG-3’
V72I Reverse: 5’-CACTCGAAATGAGCGCCCGATGACAGCCGTGCCATCAGG-3’
D109N Forward: 5’-CCATCTTGGCTGCACTGGAACTCACAGAGCCACACCCTG-3’
D109N Reverse: 5’-CAGGGTGTGGCTCTGTGAGTTCCAGTGCAGCCAAGATGG-3’.
All constructs were verified by automated sequencing.
WT and the three pathological mutant proteins were expressed as N-terminal His6-tagged
thioredoxin fusion products, containing a thrombin cleavage site, and purified before and
after thrombin cleavage according to the previously described protocol [15].
Differential scanning fluorimetry (DSF)
DSF experiments were performed using an excitation wavelength of 470–505 nm and an emis-
sion wavelength of 540–700 nm in a CFX96 Touch Biorad real-time PCR instrument (Bio-
Rad) with a temperature gradient from 20 to 90˚C in 0.2˚C/ min increments. The final protein
concentration was 0.5 mg/ mL in 20 mM Tris, 150 mM NaCl pH 7.5 (in the case of T190M the
buffer was supplemented with 2.5% glycerol) and 90 × SYPRO Orange (Sigma). Experiments
were carried out in triplicate and the averaged curves have been analyzed: melting tempera-
tures (Tm) were calculated by fitting the sigmoidal melt curves to the Boltzmann equation (S1
Fig) [16].
Limited proteolysis
WT and its pathological mutants V72I and D109N, at a final concentration of 0.85 mg/ mL,
were subjected to limited proteolysis with either α-chymotrypsin and trypsin at a final concen-
tration of 2 μg/ mL. Proteolytic digestions were performed at 37˚C and were stopped after 1, 5,
10, 20, 40 and 60 min by adding SDS sample buffer to aliquots of the reaction mixtures. The
samples were analyzed by 15% SDS-PAGE [17] and Coomassie staining.
Crystallization, data collection, structure solution and refinement
Crystals of D109N were grown by using the hanging-drop vapour diffusion method, exploring
conditions similar to those used for both WT and T190M [4,15]. Drops were prepared by mix-
ing 1 μL of protein solution (5.5 mg/ mL in 25 mM Tris, 150 mM NaCl, pH 7.5) with 1 μL of
precipitant solution (0.6–1.4 M citrate buffer; pH 6.8–7.2) and equilibrated against the reser-
voirs containing 0.7 mL of the precipitant solution. Fully-grown crystals were obtained after
two weeks at 0.7 M citrate buffer and pH 7.0, at the temperature of 277 K. Crystals of V72I did
not grow under the same conditions of D109N and were obtained by using the cross-streak-
seeding method. D109N crystals were used as seeds source and crystallization conditions
between 0.6–1.4 M citrate buffer and pH between 6.8–7.2 were explored. Drops were prepared
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by mixing 1 μL of protein solution (5.0 mg/ mL in 25 mM Tris, 150 mM NaCl and pH 7.5)
with 1 μL of precipitant solution; the drops were equilibrated against 0.7 mL of the precipitant
solution at 277 K for 3–6 days, before seeding. Fully-grown crystals were obtained after 10–15
days after seeding (best crystals obtained at 0.8 M citrate buffer, pH 7.2). Repeated streak-seed-
ing (2–3 times) at optimal precipitant conditions improved the crystal quality.
Data collections were carried out at the XRD1 beamline at ELETTRA (Trieste, Italy) [18,19]
using Pilatus 2M (Dectris) detector and 1.00 Å (D109N) and 0.976 (V72I) wavelength. Data
collection were carried out at 100 K. Crystals were quickly dipped into a cryoprotectant solu-
tion (25% v/v ethylene glycol added to the precipitant solution) and then frozen directly under
a 100 K nitrogen gas stream.
Indexing, integration and data reduction of the diffraction data were carried out by using
the XDS program [20]. Two data-set of highly isomorphous V72I crystals were merged with
XSCALE [20] for higher data completeness. Data reduction statistics of D109N and V72I data-
sets are reported in Table 1.
The structure solution of both D109N and V72I were obtained by Molecular Replacement,
using the WT crystal structure (PDB ID: 1U2C [4]) as search-model and PHASER [21] com-
puter program as implemented in PHENIX [22] crystallographic package. Rigid-body refine-
ment was initially carried out, followed by a simulated-annealing step. Several cycles of
crystallographic refinement, including positional refinement, Translation-Libration-Screw
(TLS) and individual B-factors refinement were alternated with the manual rebuilding of the
structure by using the COOT software [23]. All the refinement cycles were carried out by
using phenix.refine [24]. Solvent molecules were added to the model by using the automatic
search protocol available in phenix.refine and manually checked before being included in the
final model. Protein stereochemistry was monitored throughout the refinement process and
during manual rebuilding with MolProbity [25]. Statistics of the crystallographic refinement
are reported in Table 1. Various CCP4 [26] utility programs were used throughout the crystal-
lographic study. Molecular diagrams were prepared using the PyMol Molecular Graphics Sys-
tem [27]. The PDB codes of the deposited structures are 5N30 (V72I) and 5N4H (D109N).
Small-angle X-ray scattering measures and data processing
As previously reported for the WT protein [14], SAXS experiments for T190M were carried
out at the BM29 beamline [28] of the European Synchrotron Radiation Facility (Grenoble,
France) as 10 x 1 s exposures using a Pilatus 1M (Dectris) detector, with a sample-detector dis-
tance of 2.87 m and a wavelength of 0.99 Å. SAXS data for V72I and D109N were collected on
the P12 beamline EMBL SAXS-WAXS at PETRAIII/DESY [29] (Hamburg, Germany) as 20 x
0.05 s exposures using a Pilatus 2M (Dectris) detector, sample-detector distance 3.00 m, wave-
length 1.24 Å. Measurements were performed at six different concentrations (the ranges are
reported in S2 Table) in 20 mM Tris, 150 mM NaCl pH 7.5 (supplemented with 2.5% glycerol
in the case of T190M); the protein concentration was calculated using molar extinction coeffi-
cient at 280 nm (26595 M-1 cm-1) and measuring each sample dilution by a nanodrop spectro-
photometer. No radiation damage effects were detected comparing the scattering curves of the
collected frames.
Data were merged for each sample after normalization to the intensity of the transmitted
beam. Subtraction of the scattering of the buffer and the following processing steps were car-
ried out with PRIMUS [30] from the ATSAS 2.6.0 program package [31].
The radius of gyration Rg of the solute proteins and the forward scattering I(0) were evalu-
ated by the Guinier approximation (1939) at very small angles (s< 1.3/Rg), assuming that the
intensity is represented as I(s) = I(0) exp(-1/3(Rg
s)2) (S2 Fig), and from the entire scattering
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pattern by the program GNOM [32], that was used to compute also pair distance distribution
functions of the particles p(r) and the maximum sizes Dmax. Molecular weights (MM) were
evaluated by comparison of the calculated I(0) values with that of the standard solution of
bovine serum albumin (MM 66 kDa). The excluded volume of the hydrated protein molecule
(Vp) was obtained using the Porod approximation [33]: Vp ¼
2p2Ið0ÞR
IexpðsÞs2ds
.
Table 1. X-ray diffraction: Data collection and model refinement statistics.
D109N V72I
Space group H3 H3
Unit-cell parameters (Å)
a 71.75 71.81
c 144.00 143.99
Molecules per asymmetric unit 1 1
Wavelength (Å) 1.0000 0.9763
Resolution (Å) 48.0–1.70 35.9–1.80
Highest resolution shell (Å)a 1.76–1.70 1.86–1.80
Total observations 237820 294745
Unique reflections 30354 25641
Rmerge (%)b 0.096 (1.098) a 0.105 (1.301) a
CC1/2c 0.997 (0.883) a 0.999 (0.862) a
<I/ σ (I)> 12.0 (1.9) a 15.8 (2.1) a
Completeness (%) 99.7 (97.9) a 99.9 (99.4) a
Redundancy 7.8 (7.5) a 11.5 (11.3) a
Refinement
Number of reflections (work-set) 30326 (3042) a 25623 (2540) a
Number of reflections (test-set) 1516 (152) a 1282 (127) a
Rworkd 0.159 (0.349) a 0.154 (0.292) a
Rfreee 0.183 (0.360) a 0.182 (0.315) a
Number of non-H atoms
Protein 1765 1738
Waters 196 172
Organic 15 19
Average isotropic B factors (Å2)
Protein 33.5 36.2
Solvent 39.9 42.8
R.m.s. deviation
Bond length (Å) 0.013 0.016
Angle (deg) 1.19 1.34
Ramachandran plot
favored regions (%) 98 98
allowed regions (%) 2 2
disallowed regions (%) 0 0
a Values in parenthesis are given for the highest resolution shell
b Rmerge = ∑hkl∑jIhkl, j-<Ihkl>/ ∑hkl∑j Ihkl, j
c CC1/2 values for Imean are calculated by splitting the data randomly in half
d Rwork = ∑work-setFobs-Fcal/ ∑work-set Fobs
e Rfree = ∑test-setFobs-Fcal/ ∑test-set Fobs; Test-set: Randomly selected 5% of reflections excluded from the
structure refinement.
https://doi.org/10.1371/journal.pone.0186110.t001
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Low resolution shapes of the three mutants were produced by the ab initio program
DAMMIN [34] that employs a simulated annealing procedure to build a compact dummy
atoms (beads) model that fits the experimental data Iexp(s) to minimize the discrepancy:
w2 ¼ 1N  1
P
j
IexpðsjÞ  cIcalcðsjÞ
sðsjÞ
h i2
.
Ten independent DAMMIN runs were performed for each data set in the “slow” mode with
no symmetry assumptions (P1 symmetry): the resulting models were superimposed using the
program SUPCOMB [35] and averaged using DAMAVER [36] to identify the most typical
models representing the global shape of the three mutants in solution. The normalized spatial
discrepancy parameter (NSD) [35] obtained from DAMAVER indicated the similarity between
models used for average calculations. NSD values 1.0 are expected for similar models.
Rigid-body modeling was performed using CORAL [31], where the high-resolution X-ray
crystal structures of the Ig-like and S6 domains of the three mutants were used as inputs in the
refinement calculations. This program was employed to refine the spatial arrangement of the
two domains for the three mutants and to model clash-free configurations of the missing por-
tions of polypeptide chains (around 10 aminoacids at both N-terminal and C-terminal and the
missing linker between the Ig-like and S6 domains). CRYSOL [37] was used to evaluate the fits
to the experimental data of the respective X-ray crystal structures; CORAL was also used to
generate the approximate conformations of the missing regions keeping fixed the two domains
as in the respective X-ray crystal structures.
Inter-domain flexibility and size distribution of possible conformers for the three mutants
were quantitatively assessed by the ensemble optimization method (EOM) [38]. This method
assumes the existence of a mixture of conformations in solution; the average scattering of the
mixture fits the experimental data. In EOM, an initial random pool of 10000 conformers was
generated. In these conformers the modeled linker residues and the modeled N-terminal and
C-terminal stretches were allowed to have random-coil conformations and the S6 domain and
the Ig-like domains, obtained by the respective crystal structures of the three mutants, were
used as rigid bodies. The theoretical scattering was calculated for each generated model by
CRYSOL. A genetic algorithm (GAJOE) was used to select an ensemble of conformations
whose mixture best fitted the experimental data. Multiple runs of EOM were performed and
the obtained subsets were analyzed to yield the Rg distributions in the selected ensembles.
Once each ensemble is determined, the corresponding Shannon Entropy, reported as Rflex,
provides a quantitative measure of flexibility [39]. Using Rflex, each ensemble distribution can
be numerically compared to that of the respective random pool, the latter representing a refer-
ence for flexibility. The complementary metric Rσ (i.e. the ratio of the standard deviation
between the ensemble and the pool distributions) allows to identify potential spurious solu-
tions: values close to 1.0 are obtained when the ensemble distribution largely reproduces the
conformational space of the random pool.
Sequence alignment
Multiple sequence alignments of protein sequences were constructed in Clustal omega via the
resources of EMBL/EBI (http://www.ebi.ac.uk/Tools/msa/clustalo/).
Results and discussion
V72I and D109N mutations determine small local variations into the
crystal structure of N-terminal region of α-DG
The crystal structures of D109N and V72I have been determined to a resolution of 1.70 Å and
1.80 Å, respectively. Similarly to what observed for T190M [15], residues 50–58 and 305–315,
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as well as residues 163–179 (V72I) or 164–179 (D109N), were missing in the D109N and V72I
final models. Residues 89–91 and 181–185 belong to highly mobile loops thus showing an
inherent lower quality electron density. In addition, the region encompassing residues 159–
162 displays evidences of less populated conformations in both structures, which could not be
confidently modeled during the structure refinement. That said, both D109N and V72I struc-
tures show the typical overall folding of α-DG-Nt [4]. The Ig-like and S6 domain are linked by
a flexible loop encompassing residues 159–179, which is only partially visible in the present
models. The two pathological point mutations introduced in α-DG-Nt were identified accord-
ing to the 2Fo-Fc and Fo-Fc maps (Fig 1A and 1B) and by their effects on the local molecular
geometry.
According to the crystal structures, the two point mutations do not induce significant
changes in the domains fold nor in their mutual orientation when compared with WT. Indeed,
the superposition of the structure of WT with those of D109N and V72I gives root mean
square deviations of 0.353 Å (calculated on 227 Cα) and 0.417 Å (calculated on 226 Cα),
respectively, in line with the superposition of the WT and T190M structures (0.758 Å) [15].
The Asp109!Asn mutation introduces local changes on the molecular geometry that are
quite evident in the final refined model. The Asn109 side chain rotates nearly 120˚ around Cα-
Cβ with respect to the orientation held by Asp109 in the WT. The conformation assumed by
Asn109 allows for the establishment of H-bonds with Lys203, Glu116 and His107. Accord-
ingly, Asn109 is not engaged anymore in H-bonds with Ser112 and His111 (Fig 1A) as Asp109
is in WT. Quite surprisingly, this newly established H-bonds network does not affect the
geometry of the now untied turn including His111 and Ser112 that connect the two β-strands
D and E.
Furthermore, Asn109 also interacts with Lys203, which belongs to the S6 domain. Accord-
ing to its electron density and B-factors, Lys203 is inherently rather flexible and it is plausible
that the strength of the interaction between Lys203 and Asn109 would be rather weak. In addi-
tion, the H-bond network involving Asn109, Glu116 and Lys203 in D109N abolishes the inter-
action between Lys203 and Glu116 observed in the WT structure. Hence, it is likely that the
mutated H-bond network in D109N alters the tightness of the interaction between the Ig-like
and the S6 domains. In this respect, it must be emphasized that the Asp109!Asn mutation
not only changes the H-bond network involving residue 109, but also modifies the local elec-
trostatic potential (Fig 1C and 1D), so that the interaction of Asn109 with the surrounding
positively charged residues like Lys203 and Arg77 is affected. This is confirmed by the pres-
ence of two water molecules (HOH 548 and 621) absent in WT structure and coordinating
Arg77, thus filling the void left by the Asn109 side-chain relocation. It is therefore likely that
the change in electrostatic potential observed in D109N also affects the tightness of the interac-
tion between the Ig-like and the S6 domains.
According to the refined crystallographic model, the pathological mutation Val72!Ile has
no effect on the overall conformation of α-DG-Nt, but in this case also the local effects on the
structure around the mutated residue are quite limited. The bulkier isoleucine residue might
perturb the N-terminal part of the flexible linker connecting the two domains, with some
effects on Lys124 and Asp121 (Fig 1B and S3 Fig). These residues are solvent exposed and dis-
play, in WT, a remarkable mobility. It is worth noting that the linker region is one of the struc-
tural elements of α-DG-Nt with the highest flexibility: it is therefore difficult to confidently
assess the effect of the Val72!Ile mutation on the linker conformation, considering that it is
only partially defined in the refined V72I model. It is also worth of note that the conformation
of the modeled part of the linker in V72I is essentially the same as that observed in T190M, but
rather different from what observed in WT, pointing to an effect not related to the specific
presence of Ile72.
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Conformational stability of the pathological mutants
Conformational stabilities of the three pathological mutants as compared to WT were assessed
by limited proteolysis and DSF assays.
Considering that conformational parameters such as solvent accessibility and segmental
mobility are known to correlate with exposed proteolytic sites [40], limited proteolysis analysis
Fig 1. V72I and D109N crystal structures. Details of the superimposition of the WT with D109N (A) and V72I crystal structures
(B). WT, D109N and V72I are represented as ribbon. Selected residues are represented as stick-and-ball, with WT (PDB ID:
1U2C) colored in green, D109N colored in blue and V72I colored in orange. Residues belonging to WT are labelled with WT
superscript in panels (A) and (B). The models are overlaid by D109N σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in
grey) (A) and by V72I σA-weighted 2Fo-Fc map (contoured at 1.0 σ and colored in grey) and Fo-Fc map (contoured at 3.0 σ and
colored in green) (B). Electrostatic potential maps of WT and D109N are represented in panel (C) and (D) respectively. The
electrostatic potential (in kbT/ec units) is mapped on solvent-accessible surface of the WT and D109N pathological mutant
accessible surfaces. Negative potential is colored in blue, positive potential in red. Color scale varies between -2 and +2.
Molecular models (stretch 105–116) are represented as ribbons with selected residues depicted as stick-and-ball.
https://doi.org/10.1371/journal.pone.0186110.g001
Structural characterization of the V72I, D109N and T190M mutants of the α-DG N-terminal domain
PLOS ONE | https://doi.org/10.1371/journal.pone.0186110 October 16, 2017 8 / 23
was performed with two different proteases (respectively α-chymotrypsin and trypsin) in
order to identify potential flexible and exposed regions. The results shown in Fig 2 suggest
only slight differences in susceptibility to proteolysis of V72I and D109N with respect to WT
protein, not as striking as those recorded in a comparative tryptic analysis of the T190M
mutant [15].
In order to investigate further whether the pathological mutations are associated with varia-
tion in conformational stability, DSF was performed. This assay monitors thermally-induced
protein unfolding by the binding of a fluorescent dye to the hydrophobic core of the protein as
it becomes exposed, with an increase in fluorescence emission as the dye binds. From the
unfolding curve thus the Tm of a protein can be calculated, which is indicative of its thermal
and conformational stability: a shift towards lower temperatures in the Tm of a protein variant
relative to that of the WT is evidence of its destabilization [16]. Therefore, the analysis of the
DSF curves and Tms are especially useful for a qualitative comparison of the mutants thermal
stabilities. Fig 3 compares the changes in fluorescent signal of the WT and mutant proteins
during thermal unfolding in the presence of the dye. WT, V72I and D109N show very low and
flat background fluorescence in the pre-transition region, while T190M is characterized by a
quite high fluorescence in the pre-transition region, often symptom of exposed hydrophobic
residues [41]. This finding is in accordance with the substitution of the polar side chain of Thr
with a bulkier and apolar group such as the methylthio group of the Met that can create a bind-
ing site for the hydrophobic dye in the native state. Even if all the resulting denaturation curves
point to a two-transitions unfolding process, as it has been observed in several proteins com-
posed by two domains that independently fold, the profiles are dramatically different, suggest-
ing that the single point mutations deeply influence the protein conformation/stability in
solution. In particular, the first transition is much sharper (i.e. more cooperative) for V72I and
D109N than for T190M and WT. The Tm values (summarized in the insert of Fig 3) could be
calculated, by fitting the data to a Boltzmann Sigmoid only for the first transition since the sec-
ond is not sufficiently defined. The fitting was especially problematic for the T190M case, due
to its large pre-transition fluorescence. Two mutants (D109N and T190M) were characterized
by an increase in Tm relative to WT, while for V72I a small decrease was observed. The second
Fig 2. Limited proteolysis analysis. Protease digestion of α-DG-Nt WT and its pathological mutants V72I
and D109N by α-chymotrypsin (A) and trypsin (B) for 1, 5, 10, 20, 40 and 60 min. Undigested samples served
as the zero time point (0).
https://doi.org/10.1371/journal.pone.0186110.g002
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transition profiles suggest an increased Tm of the mutants with respect to the WT, although in
this cases the Tm could not be calculated because it was not possible to reach the aggregation
region (i.e. the endpoint of the transition), even increasing the final temperature to the upper
range value of the instrument.
Association state and overall size parameters of the pathological
mutants in solution
In order to assess whether the single point mutations associated to pathological states impact
on the conformation of α-DG-Nt in solution, SAXS experiments were performed on the three
mutants at different concentrations (S1 Table) without observing systematic changes due to
solute concentrations or any interparticle interaction (S4 Fig): therefore the analysis was per-
formed on the curves collected for most concentrated samples. Fig 4 displays the processed
scattering data collected for the highest concentration of each mutant, and S1 Table compares
the resulting overall size parameters to previously collected WT data [14] (additional details on
SAXS structural parameters are reported in S2 Table).
Fig 3. Thermal denaturation assay using DSF with SYPRO dye. Comparison of unfolding fluorescent curves for the WT α-DG-Nt and its pathological
mutants; the melting temperature (Tm) values from the Boltzmann Sigmoid fitting of the first transition of the curves are reported in the insert. Experiments
were performed in triplicate and the averaged curves are shown.
https://doi.org/10.1371/journal.pone.0186110.g003
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The Vp and the MM calculated for all mutants (S1 Table) were consistent with the values
expected for a monomeric species even at relatively high (up to 7 mg/ml) concentrations and
are in agreement with the MM estimated from the primary sequences (around 28.5 kDa).
The computed distance distribution functions p(r) are compared to the profile obtained for
the WT protein in Fig 4D. All the profiles display a single peak with a tail, a pattern indicative
of proteins having elongated structures, but the significant change in the maximum dimen-
sions of the mutants, combined with a significant variation in the radius of gyration (Rg) (Fig
4E and S1 Table), are further evidence that the pathological point mutations affect the confor-
mation of α-DG-Nt.
In details, the mutations Asp109!Asn and Thr190!Met led to a significant increase in
the maximum dimensions (with Dmax increased from 90 ± 3Å for WT to 95 ± 3Å and to
100 ± 3Å for D109N and T190M respectively) and in the Rg values (from 25.20 ± 0.04Å for the
WT to 26.40 ± 0.04Å and to 27.20 ± 0.04Å for D109N and T190M, respectively), suggesting a
more extended shape of the two pathological mutants compared to the WT protein. On the
contrary, the single mutant V72I shows a decrease both in Dmax (from 90 ± 3Å for WT to
80 ± 2Å for V72I) and in the Rg value (from 25.20 ± 0.04Å for the WT to 24.20 ± 0.04Å for
V72I), pointing to a more compact shape as compared to the WT protein.
Fig 4. Experimental X-ray scattering data and the obtained fits of the three pathological mutants of
α-DG-Nt: A) V72I; B) D109N and C) T190M. Experimental SAXS patterns, scattering calculated from the
respective crystallographic models with added missing regions obtained by CORAL (fit crystal) keeping fixed the
two domains and scattering calculated from models obtained by CORAL (fit CORAL) are plotted as indicated.
The plots display the logarithm of the scattering intensity as a function of momentum transfer s = [4πsin(θ/2)]/λ
(Å-1), where θ is the scattering angle and λ is the X-ray wavelength. The zoomed regions of these graphs at low
angles are presented in the inserts. The comparison of the distance distribution functions obtained for the WT
and the three pathological mutants of α-DG-Nt are presented in panel (D), the corresponding Rg values are
plotted in panel (E).
https://doi.org/10.1371/journal.pone.0186110.g004
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Similarly to what determined by the SAXS experiments performed on the WT protein [14],
all the mutants in solution have a significantly more elongated conformation than the respec-
tive crystallographic models (S5 Fig). Indeed, the scattering curves computed by the CRYSOL
program [37] from the crystallographic models (PDB_IDs: 5N30 for V72I, 5N4H for D109N
and 4WIK for T190M [15]) give a poor fit to the experimental data (not shown), even after the
reconstruction of the missing regions (around 10 aminoacids at both N-terminal and C-termi-
nal and the missing linker between the two domains that are kept fixed) using the program
CORAL [31] (S1 Table Χcrystal, Fig 4 fitcrystal with the zoomed portions at low angles in the
inserts). Despite SAXS cannot characterize a molecular structure at a resolution level compara-
ble to that provided by X-ray crystallography, it allows to define structural models in solution
devoid of the constrains imposed by the packing forces featuring crystal structures. In our
models packing forces may influence the relative orientation of the Ig-like and S6 domains
that in solution gain a certain degree of freedom assured by the highly flexible loop connecting
them. This may have relevant effects on the overall conformation of the α-DG N-terminal
domain that is expected to influence the shape of the molecule and, accordingly, the very low-
resolution part of the scattering curve.
Effects of the pathological mutations on the shape of the N-terminal
region of α-DG in solution
The macromolecular shapes of the three mutant proteins in solution have been reconstructed
in parallel by ab initio modeling and by rigid-body modeling.
All the 10 independent solutions for each mutant (Fig 5), reconstructed from the X-ray
scattering data using DAMMIN [34], showed a good fit to the experimental curves (Χab-initio in
S1 Table). Thus they were averaged to obtain the final low-resolution models of the three
mutant proteins with quite low NSD values (0.698 ± 0.018, 0.570 ± 0.039 and 0.533 ± 0.031, for
V72I, D109N and T190M, respectively), indicating that the multiple solutions built by the pro-
gram are very similar to each other. The comparison of the resulting ab initio models with that
of the WT suggests that small but significant rearrangements (at low resolution) in the orienta-
tion of the two domains occur, leading to a more extended structure for D109N and T190M
and to a more compact conformation for V72I (Fig 5).
Fig 5. Comparison of the structural models of the WT and the three pathological mutants of α-DG-Nt.
Averaged and filtered ab initio bead models obtained with DAMMIN (semitransparent surfaces) overlaid to the
typical CORAL models (green, red, blue and violet cartoon representations for the folded Ig-like and S6 domains,
spheres for the restored missing fragments of WT (A), V72I (B), D109N (C) and T190M (D), respectively).
Residues involved in the three pathological mutations are represented by sticks and colored in orange.
https://doi.org/10.1371/journal.pone.0186110.g005
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In order to get more detailed information exploiting the respective high-resolution crystal
structures, with the Ig-like and S6 domains treated as rigid bodies, the program CORAL [31]
was used to optimize the relative orientations of the two domains and to reconstruct the miss-
ing regions. Multiple runs were performed and yielded variable conformations, all providing
good fits to the experimental data (i.e. Χ in the range of 1.0–1.1 for V72I, 1.1–1.6 for D109N
and 1.1–1.7 for T190M). Even if this variety of configurations suggests a significant flexibility
of this region (see below for the discussion of the inter-domain flexibility), the good fit of the
best rigid-body models of the mutants (ΧCORAL in S1 Table and fitCORAL in Fig 4) indicates
that these models provide a good representation of the average conformations. These results
confirm that the pathological mutant proteins have a more extended shape in solution than
that observed in the crystal lattice (as previously assessed for the WT protein). One of the pos-
sible reasons for that is the absence of the packing forces in solution together with the two-
domain structure of the proteins which are connected by the flexible linker. In this respect it is
interesting to note that the positions of the centers of masses of the S6 domains in all the crys-
tallographic models nicely overlap (S6 Fig) and are much closer to the center of mass of the Ig-
like domain than the respective CORAL models. As a quantitative measure of structure com-
pactness, the distances between centers of masses of the two domains in the crystallographic
models (29.9 Å, 29.7 Å, 29.6 Å and 29.6 Å in the WT, D109N, V72I and T190M models,
respectively) have been compared to the respective CORAL models (34.4 Å, 36.6 Å, 33.0 Å and
37.4 Å in the WT, D109N, V72I and T190M models, respectively), confirming the existence in
solution of rather elongated conformations that are more flexible than what their crystal struc-
tures suggested. Moreover, this comparison highlights that the three mutations significantly
impact on the protein conformation, in agreement with what observed for the respective SAXS
model envelopes.
It is interesting to note that, comparing the CORAL models of the three mutants to that of
the WT one, the S6 domain appears to be rotated to different extents around the Ig-like
domain. In the case of both V72I and D109N, the mutated residues (whose lateral chains are
highlighted by orange sticks in Fig 5) are mapped on the surface of the Ig-like domain facing
the S6 domain, and might induce a rearrangement in the mutual orientations of the two
domains either directly or by an indirect effect mediated by the linker. Such an explanation
cannot be invoked for the T190M mutation, which is located on the external surface of the S6
domain.
Pathological mutations alter the flexibility of the N-terminal region of α-
DG in solution
The presence of disordered regions in the crystal structure of the WT protein, has been
reported to indicate a certain degree of inter-domain flexibility that could account for the
observed conformational variability in solution [14].
The occurrence of possibly increased inter-domain flexibility in the three pathological
mutants with respect to the WT was investigated using two different approaches. An essen-
tially qualitative approach, the so called normalized Kratky plot [42], allows to directly com-
pare objects of different shape and size. In such a plot, folded compact globular proteins
provide a bell-shaped curve at low angles with a maximum at sRg 1.75 [42]. Deviations from
this behavior point to particle flexibility as in the case of the WT protein, whose maximum
falls at sRg 2.1 (Fig 6). The plots for D109N and T190M both show a broadening of the bell-
shaped curve and a shift of the maxima to larger sRg values, expected for more extended and
flexible particles, while for V72I the curve is slightly sharper. In any case, the plots of the three
mutant proteins are characterized by upward trends at higher sRg values (i.e. higher scattering
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angles) as compared to the more downward trend observed for the WT, an indication of
increased flexibility in these former.
In the second, more quantitative approach, the ensemble optimization method (EOM) [38]
was employed in order to analyze inter-domain flexibility and size distribution of possible
multiple configurations in solution and to obtain typical optimized ensembles with a good fit-
ting to the experimental scattering data (fitEOM in Fig 4 and ΧEOM S1 Table).
The EOM analysis for the three mutants are compared to WT in Fig 7 as a size distribution,
plotting the Rg of the structures forming the initial random pool and the selected ensembles.
The Rg distributions of these ensembles (Fig 7 solid lines) are nearly as broad as the distribution
Fig 6. Normalized Kratky plots. Comparison of Kratky plots for the pathological mutants A) V72I, B) D109N
and C) T190M with that of WT α-DG-Nt.
https://doi.org/10.1371/journal.pone.0186110.g006
Structural characterization of the V72I, D109N and T190M mutants of the α-DG N-terminal domain
PLOS ONE | https://doi.org/10.1371/journal.pone.0186110 October 16, 2017 14 / 23
of randomly generated models (Fig 7 dashed lines) supporting the hypothesis of considerable
inter-domain flexibility. Moreover the quantification of the flexibility of the WT protein
(ensemble Rflex = 83.9% versus pool Rflex = 88.5%) and of the three mutants V72I (ensemble
Rflex = 81.9% versus pool Rflex = 87.7%), D109N (ensemble Rflex = 85.8% versus pool Rflex =
86.6%) and T190M (ensemble Rflex = 82.7% versus pool Rflex = 88.8%) confirmed random
motion of the Ig-like domain with respect to the S6 domain. The quality of the ensemble solu-
tions were further validated by the values of Rσ that were close to 1.
However, it is interesting to note that the three mutants display alterations in the bimodal
profile that characterizes the distribution of size observed for the WT protein (Fig 7 green
solid lines). In detail for V72I the profile is mainly unimodal characterized by a broader single
peak: even if its maximum is slightly shifted to more compact models with Rg about 21–25 Å
(60.4% of the total population), there is an increased fraction of extended models with inter-
mediate Rg around 25–30 Å. The distribution for D109N and T190M is still bimodal like the
WT but beside the predominant fraction of relatively compact models, whose peak is sharper
for D109N with Rg about 21–24 Å (43.1%), while slightly shifted to less compact models for
T190M, with Rg about 21–27 Å (61.4%), both mutants show a significant increase in the popu-
lation of elongated models with intermediate Rg around 25–30 Å. Indeed, although the small
fraction of more extended models with Rg about 30–37 Å present in the WT (16.5%) can be
still observed in D109N (15.3%) and is even increased in T190M (27.5%), but is scarcely repre-
sented in V72I (8.1%), all three mutants share a significant fraction with intermediate Rg
around 25–30 Å (25.8%, 29.2% and 22.5% for V72I, D109N and T190M, respectively) that is
remarkably less populated in the distribution of the WT protein (18.6%).
Functional implications of the pathological mutations of α-DG
The present analysis of the conformational variability of the mutants of α-DG-Nt in solution
at low resolution pinpoints to inter-domain flexibility as an important structural determinant
mediating the pathological alterations induced by the missense point mutations, that in
human result into primary dystroglycanopathies [12,13,43].
To this respect it is worth noting that in the presence of a single wild-type copy of the DG
allele no haploinsufficiency, or in any case no phenotype involving DG has been reported in
the parents and/ or family of the compound heterozygous patient studied by Dong and col-
leagues. This finding suggests there are no relevant dominant effects in this case [13] nor in the
heterozygous relatives carrying the T192M mutation [12]. In accordance with the heterozygous
compound human phenotype, apparently they have never been co-selected [44]. No single nucle-
otide polymorphisms have been reported in the human DG gene within the region corresponding
to its N-terminal Ig-like domain [45,46]. However, it is interesting to note that the sequence align-
ments for representative members of vertebrate α-DG regions containing these three mutations
(S3A Table for Val72 and Asp109 according to the murine Ig-like domain of α-DG and S3B
Table for Thr 190) reveal that Val72 and Thr190 are highly conserved across evolution, at least in
higher animal groups. On the contrary, Asp109 has been apparently subjected to a less stringent
negative selection pressure. Indeed Reptiles and Amphibians show a conservative substitution
(Asp!Glu in green in S3A Table) in position 109 corresponding to the murine α-DG; in Fish
beside the same conservative substitutions, also not conservative mutations can be observed (in
red in S3A Table); in Birds the same pathological mutation Asp!Asn seems to be quite common
(in yellow in S3A Table). However, in chicken [47] no missense mutation hitting the α-DG-Nt
has been described to cause dystroglycanopathies. Among Fish, in zebrafish, where DG knock-
down has been reported to cause a muscular dystrophy [48], all these three positions are con-
served, even if a missense mutation (V567D) has been reported only within the second C-
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terminal Ig-like domain of α-DG, completely abolishing its presence [49]. Most importantly these
three positions are highly conserved in Mammals and in particular in dog and cat, where muscu-
lar dystrophies have been reported in which α-DG glycosylation [50] or expression levels [51] are
respectively altered. Finally in humans these three α-DG pathological mutations are known to
lead to hypoglycosylated α-DG and thus to primary dystroglycanopathies of different severity
[12,13,43]. To bind its physiological ligands in ECM (laminin, agrin, perlecan) mature α-DG
Fig 7. Rg distributions for the EOM models. Comparison of Rg distributions of the pathological mutants A)
V72I, B) D109N and C) T190M with that of WT α-DG-Nt. The distributions for the initial random pools of
models are shown by dot lines and the solid lines correspond to the selected ensembles. The representative
conformations are shown near the distributions: compact on the left, intermediate in the middle and extended
conformation on the right. Folded domains are depicted as cartoons (V72I in red, to D109N in blue and to
T190M in violet); linkers and the N-terminal and C-terminal reconstructed regions are represented by spheres.
https://doi.org/10.1371/journal.pone.0186110.g007
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requires a correct glycosylation that depends on a complex pattern of post-translational modifica-
tions. Indeed, during maturation a cascade of enzymatic reactions leads to matriglycan [7],
recently proposed name for the glycan section of α-DG that actually forms a bridge with the lami-
nin LG domains. The impact of these pathological mutations on α-DG-Nt, which is known to
assist the bifunctional glycosyltransferase LARGE during the matriglycan extension stage [7,11]
might depend on their ability to negatively affect the interaction of α-DG with LARGE and/ or
make α-DG-Nt unable to properly assist LARGE in its enzymatic activity. From a structural
point of view the crystallographic structures here discussed point to local differences with
respect to the WT structure. It cannot be excluded that the local alterations observed in
D109N and V72I may negatively affect the molecular determinants of LARGE recognition
and/ or binding by α-DG. Such a hypothesis clearly requires a more detailed structural study
in order to be correctly addressed.
Despite showing similar crystal structures, the three pathological mutants here discussed
display a strikingly different behavior in solution, not only from each other but also from the
WT protein. It has already been observed that the crystallographic models do not fully account
for α-DG-Nt structure in solution nor for its conformational variability [14]. The framework
resulting from a previous SAXS study suggests that multiple conformations and their associ-
ated populations observed in solution are shared features of both human and mouse α-DG
[14], pointing to functional implications for the α-DG structural plasticity.
Indeed, LARGE action requires different catalytic steps involving two distinct glycosyl-
transferases domains that in turn extend matriglycan [7,11,52]. LARGE activity leads to the
synthesis of a glycan of remarkably high molecular weight, due to the decoration of the mucin-
like region of α-DG with several [-glucuronic acid-β1,3-xylose-α1,3-] units, that in mature α-
DG spans more than 100 nm in length [8]. It is safe to assume that α-DG-Nt would need a cer-
tain degree of conformational variability in order to assists LARGE into such a complex matri-
glycan elongation. The SAXS study here presented clearly indicate that the pathological point
mutations studied, while not largely affecting the α-DG-Nt structure in crystal, do affect its
conformation in solution. The effects on the average conformations of the three pathological
α-DG mutants T192M, V72I and D109N clearly emerged from shape reconstruction and from
rigid-body fitting. The impact of the pathological mutations on the α-DG-Nt conformation
are further confirmed by the analysis of the conformational ensembles variability. EOM analy-
sis reveals that the mutations do affect the bimodal partition observed in human and mouse α-
DG-Nt, with a general increase in the mutants inter-domain flexibility.
It is worth noting that none of the mutations under analysis seem to affect significantly the
overall stability of the DG core protein as far as its expression, trafficking and membrane tar-
geting is concerned [12,13]. Interestingly, the increased conformational flexibility of the
mutant proteins seems to be related to a gain in their thermal stability (with the exception of
V72I), quantified by DSF. This result is quite unexpected as thermal stability of a protein is
commonly associated to its structural rigidity. Nevertheless, an increasing number of studies
arises the need to reconsider such a notion [53]. For example, comparing thermodynamic
parameters of the unfolding process of thermostable and mesostable proteins, it has been
found that thermostability may be attributed to reduced entropy changes between unfolded
and folded states, due to an enhanced number of conformations that can be sampled by the
folded protein, especially at higher temperatures. In other words, an increased conformational
mobility of the folded state reduces the entropic contribution to the ΔG of the folded!
unfolded transition, shifting melting temperature Tm towards higher values [54,55]. This may
explain the increased Tm values measured for D109N and T190M, and the reduced Tm value
of V72I, with respect to WT. Indeed, V72I populates conformational states that are more
densely packed than those sampled by WT and its average conformation is more compact, as
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also supported by its lower maximum dimension (Dmax) and radius of gyration (Rg) compared
to WT. Moreover, the relative increased resistance to proteolysis, displayed by the mutant pro-
teins, despite their enhanced protein flexibility, may be explained assuming that the exchange
among compact and extended protein conformations occurs at a frequency that is higher with
respect to the time scale of the proteolysis. Conversely, the increased conformational flexibility
of the mutants probably perturbs the delicate equilibrium between structural rigidity and flexi-
bility that must be assured to properly bind other proteins; this may account for the presence of
some relevant post-translational effect of the mutations, i.e. a reduced affinity toward LARGE,
resulting in a significant hypoglycosylation of the α-DG with loss of its functionality. Interest-
ingly, we have recently reported that the mutation T190M reduces the mobility of α-DG within
the membrane, as well as its clustering within the actin-rich domain, perturbing cell migration
[56].
Although the mutants show remarkable differences in their conformations in solution, it is
not easy to identify a correlation with different phenotypes featuring the related diseases.
Indeed, the T192M mutation is associated to a severe form of limb-girdle muscular dystrophy
with cognitive impairment, whereas the mutations V74I and D111N are related to a mild form
of muscular dystrophy with asymptomatic hyperCKemia. Remarkably, the two diseases dis-
played apparently similar hypoglycosylated forms of α-DG. It can be hypothesized that such
different phenotypes could be due to a different residual glycosylation of α-DG resulting in a
differently reduced binding affinity towards its physiological partners that cannot be evaluated
with the available analytical techniques. This is consistent with previous reports that pointed
out the lack of correlation between the glycosylation levels of α-DG and clinical severity of the
pathology [57]. A deeper insight into the biochemical mechanism underlining primary dystro-
glycanopathies could be achieved accumulating structural information on LARGE and on the
way it interacts with α-DG-Nt in order to correctly glycosylate the α-DG mucin-like domain, a
goal that we will hopefully reach in the next future.
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